Company Profile

Immunocore Holdings plc (NASDAQ: IMCR)
5:00 PM UTC, 07/03/24
Last: $36.02 Change: +1.22 %Change: +3.51% Volume: 283,322
Detailed Quote
Open: $ 35.00   Volume: 283,322
High: $ 36.31   Yield(%) 0.00
Low: $ 34.68   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 1.74B
EPS ($) -1.20   Shares Out: 50.01M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -19.65
% Price Change (last 13 weeks): -45.18
% Price Change (last 26 weeks): -51.42
% Price Change (last 52 weeks): -40.57
% Price Change (year to date): -49.06
Management Effectiveness
Return on Equity (%): -15.76
Return on Assets (%): -9.90
Return on Invested Capital (%): -68.84
Profitability
Gross Profit Margin (%): 97.94
Net Profit Margin (%): -22.17
Operating Profit Margin (%): -23.91
Price & Volume
50-day Moving Average: $48.03
200-day Moving Average: $56.55
Avg. Daily Vol. (last 50 days): 874,763
Avg. Daily Vol. (last 200 days): 524,619
52-wk high: $76.98
52-wk low: $33.05
Bid: $33.08
Ask: $36.58
Company Information
Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom.
Immunocore Holdings plc
92 Park Drive Milton Park
Abingdon OX OX14 4RY

Phone: 44.1235.438600
Fax: n/a
http://www.immunocore.com
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 7.37
Cash Flow ($): -1.03
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 13.34
Price/Book (x): 9.26
Price/Cash Flow (x): 1131.70
Financial Strength
Quick Ratio (x): 3.77
Current Ratio (x): 3.80
LT Debt/Equity (x): 22.41
Total Debt/Equity (x): 22.78



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.